Tag: Vortioxetin
DCGI approves Brintellix in India for major depressive disorder
Lundbeck India has announced the launch of Brintellix (Vortioxetine), a novel multimodal antidepressant, which has been specifically designed to inhibit serotonin reuptake and modulate serotonergic receptor activity of the neurons in the brain of affected patients...…………...